ÂÜÀòÂÒÂ×

Karin Hehenberger is a highly experienced medical professional currently serving as President of Lyfebulb and Chief Medical Officer at Patient Care America since March 2024. With a robust background in medical consulting and advisory roles, Karin functions as a Medical Advisor for 3B Future Health Fund I & II and as a Medical and Scientific Consultant for Helsinn Group since January 2011. Additionally, Karin is an active board member for various organizations, including AnaCardio, Diamyd Medical, AADI biosciences, the American Diabetes Association (NY/NJ), and the Rolf Luft Foundation for Diabetes Research. Karin's previous role as Chief Executive Officer at Lyfebulb focused on empowering patients with chronic diseases. Academic credentials include a post-doctoral degree from Harvard Medical School and an MD/PhD from Karolinska Institutet.